Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Interferon associated retinopathy.
Hayasaka S, Nagaki Y, Matsumoto M, Sato S.
Br J Ophthalmol. 1998 Mar;82(3):323-5. Review. No abstract available.
Similar articles
Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity.
Oppenheim Y, Ban Y, Tomer Y.
Autoimmun Rev. 2004 Jul;3(5):388-93. Review.
Interferons, serotonin and neurotoxicity.
Menkes DB, MacDonald JA.
Psychol Med. 2000 Mar;30(2):259-68. Review.
Ocular manifestations of hepatitis C virus infection.
Zegans ME, Anninger W, Chapman C, Gordon SR.
Curr Opin Ophthalmol. 2002 Dec;13(6):423-7. Review.
[Interferon and plasma lipids].
García-Escaño MD, Andrade RJ, González-Santos P.
Med Clin (Barc). 2000 Jan 22;114(2):74-6. Review. Spanish. No abstract available.
[Neurologic side effects of interferon therapy].
Kohira I.
Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):610-3. Review. Japanese. No abstract available.
Interferon-induced granulomatous lung disease.
Marzouk K, Saleh S, Kannass M, Sharma OP.
Curr Opin Pulm Med. 2004 Sep;10(5):435-40. Review.
Chronic hepatitis C, depression and interferon.
Horsmans Y.
J Hepatol. 2005 Jun;42(6):788-9. Epub 2005 Apr 1. Review. No abstract available.
[Adverse effect of interferon therapy and its prevention].
Sainokami S, Hino K, Nishiyama Y, Shimoda K.
Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):1026-33. Review. Japanese. No abstract available.
Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
Berk DR, Mallory SB, Keeffe EB, Ahmed A.
Clin Gastroenterol Hepatol. 2007 Feb;5(2):142-51. Epub 2006 Aug 17. Review. Erratum in: Clin Gastroenterol Hepatol. 2007 Jun;5(6):765.
Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.
Van Thiel DH, Friedlander L, De Maria N, Molloy PJ, Kania RJ, Colantoni A.
Hepatogastroenterology. 1998 Mar-Apr;45(20):328-30. Review.
Neuropsychiatric changes in HIV/hepatitis C coinfected patients undergoing interferon therapy.
Corcoran CP.
J Assoc Nurses AIDS Care. 2003 Sep-Oct;14(5 Suppl):80S-86S. Review.
Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C.
Crone CC, Gabriel GM, Wise TN.
Cleve Clin J Med. 2004 May;71 Suppl 3:S27-32. Review.
[Damage to retinal vasculature].
Sevilla E.
Bull Soc Belge Ophtalmol. 2007;(304):67-70. Review. French.
Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.
Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J.
Clin Infect Dis. 2004 Dec 1;39(11):1724-9. Epub 2004 Nov 8. Review.
[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C].
Khalil A, Lucidarme D, Desurmont P, Hamdan-Khalil R, Filoche B.
Gastroenterol Clin Biol. 2005 Feb;29(2):193-6. Review. French.
The role of nursing in managing treatment-associated adverse effects in patients with hepatitis C.
Leone NE.
Gastroenterol Nurs. 2002 Sep-Oct;25(5):201-3. Review.
Filters: Manage Filters